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OBJECTIVE — Hospital hyperglycemia, in individuals with and without diabetes, has been
identiﬁed as a marker of poor clinical outcome in cardiac surgery patients. However, the impact
of perioperative hyperglycemia on clinical outcome in general and noncardiac surgery patients
is not known.
RESEARCHDESIGNANDMETHODS — Thiswasanobservationalstudywiththeaim
of determining the relationship between pre- and postsurgery blood glucose levels and hospital
length of stay (LOS), complications, and mortality in 3,184 noncardiac surgery patients consec-
utively admitted to Emory University Hospital (Atlanta, GA) between 1 January 2007 and 30
June 2007.
RESULTS — The overall 30-day mortality was 2.3%, with nonsurvivors having signiﬁcantly
higherbloodglucoselevelsbeforeandaftersurgery(bothP0.01)thansurvivors.Perioperative
hyperglycemia was associated with increased hospital and intensive care unit LOS (P  0.001)
as well as higher numbers of postoperative cases of pneumonia (P  0.001), systemic blood
infection (P  0.001), urinary tract infection (P  0.001), acute renal failure (P  0.005), and
acutemyocardialinfarction(P0.005).Inmultivariateanalysis(adjustedforage,sex,race,and
surgery severity), the risk of death increased in proportion to perioperative glucose levels;
however, this association was signiﬁcant only for patients without a history of diabetes (P 
0.008) compared with patients with known diabetes (P  0.748).
CONCLUSIONS — Perioperative hyperglycemia is associated with increased LOS, hospital
complications, and mortality after noncardiac general surgery. Randomized controlled trials are
needed to determine whether perioperative diabetes management improves clinical outcome in
noncardiac surgery patients.
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atients with diabetes are more likely
to undergo surgery than are those
without diabetes (1,2). Surgery in
diabetic patients is associated with longer
hospital stay, higher health care resource
utilization, and greater perioperative
mortalitythaninnondiabeticsubjects(1–
3). The higher morbidity and mortality in
diabetic patients relates in part to the
heightened incidence of comorbid condi-
tions including coronary heart disease,
hypertension, and renal insufﬁciency
(4,5), as well as the adverse effects of hy-
perglycemia in clinical outcome (6–8).
Evidence from observational studies sug-
gests that in surgical patients, with and
without diabetes, improvement in glyce-
mic control positively affects morbidity
and mortality (9,10). The stronger body
of evidence comes from the setting of car-
diac surgery and critically ill patients ad-
mitted to the intensive care unit (ICU). In
this setting, perioperative hyperglycemia
is associated with an increased rate of
deep sternal wound infections, hospital
complications, and mortality (11,12),
and improvement of glycemic control re-
duces the rate of postoperative complica-
tions, length of hospital stay, and
mortality (8,12,13). Similarly, the devel-
opment of perioperative hyperglycemia
has also been shown to be a sensitive pre-
dictor of nosocomial infection in small
observational studies in general surgery
(9,10,14). Few studies, however, have re-
ported on the association between glu-
cose levels and hospital mortality in
general surgery patients, and it is not
known whether the severity of hypergly-
cemia and the timing of hyperglycemia
before or during the postoperative period
lead to the increased mortality and hospi-
talcomplications.Accordingly,theaimof
this study was to determine 1) the rela-
tionship between perioperative hypergly-
cemia and diabetes on clinical outcome
(lengthofhospitalstay,needforICUcare,
infectious complications, acute renal fail-
ure [ARF], respiratory failure, and myo-
cardial infarction) and 2) the impact of
perioperative hyperglycemia on survival
after adjustment for known prognostic
factors in patients undergoing general
noncardiac surgery. We hypothesized
that general surgery patients with periop-
erative hyperglycemia would experience
higher hospital complications and mor-
tality compared with patients with nor-
mal glucose levels.
RESEARCH DESIGN AND
METHODS— Medical records from
all patients who underwent inpatient
noncardiac surgical procedures at Emory
University Hospital, a tertiary academic
center in Atlanta, Georgia, between 1 Jan-
uary 2007 and 30 June 2007 were in-
cluded in the analysis. The patient list
was obtained from the operative room
electronic medical records. We included
patients from general surgery, neurosur-
gery, surgical oncology, orthopedic, vas-
cular, thoracic, urology, otolaryngology
(except tonsillectomy), and gynecology
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was included in patients with more than
one surgical procedure. We excluded pa-
tientswithoutpatientsurgicalprocedures
orthosewithalengthofstay(LOS)24h
orwithminorsurgicalproceduresinclud-
ing endoscopic procedures and ophthal-
mologicsurgery.Thestudywasapproved
by the Emory University Institutional Re-
view Board.
We collected data on demographics,
LOS, 30-day mortality rate, inpatient
laboratory values such as whole blood
glucose, plasma blood glucose, and creat-
inine 1 day before, 1 day after surgery
(postsurgery day 1), and within the ﬁrst
10 days after surgery. Diabetes was de-
ﬁned by ICD-9 codes (250). Hospital
complications including myocardial in-
farction (410.51, 410.71, 410.81, and
410.91), pneumonia (481, 482, 485, and
486), sepsis and bacteremia (0.38, 790.7,
785.52, and 995.9), skin infection (681,
682, 685, 686, and 707), and urinary
tract infection (599.0 and 590.8) were
identiﬁed.ARFwasdeﬁnedasanincrease
in serum creatinine 0.5 mg/dl from
baseline during the hospital stay. Mortal-
ity rate was assessed in the hospital and
within a 30-day period after surgery. The
30-day mortality was captured using hos-
pital records, outpatient medical records,
and the database from the National Sur-
gical Quality Improvement Program.
Severityofsurgerywasgradedaslow,
intermediate, and high based on Ameri-
can College of Cardiology/American
HeartAssociationpreoperativeevaluation
guidelines (15). High-risk procedures in-
cluded aortic and other major vascular
and peripheral arterial surgical proce-
dures. Intermediate risk procedures in-
cluded carotid endarterectomy and head
and neck, intraperitoneal and intratho-
racic, orthopedic, and prostate surgical
procedures. Low-risk procedures in-
cluded superﬁcial procedures (proce-
dures involving skin, skeletal muscle, or
superﬁcial fat) and breast surgery.
Data analysis
Comparison of baseline demographics
and clinical characteristics between
groups were analyzed by nonparametric
Wilcoxon tests for continuous variables.
For categorical variables, 
2 tests were
used. Multiple logistic regression and ad-
justed odds ratios were used to determine
the inﬂuence of covariates including de-
mographic and clinical characteristics on
mortality rates. Multivariate linear regres-
sion was used to study the effects of these
covariates on LOS. P  0.05 was consid-
ered signiﬁcant.
RESULTS— Theoriginaldataﬁlecon-
sisted of 3,588 medical records. We ex-
cluded 374 patients with multiple
admissions and 30 patients aged 90
years. The patient population included
3,184 patients, 53.8% female and 46.2%
male, with mean  SD age 56.5  16
years and BMI 27.6  7.3 kg/m
2, who
underwent noncardiac surgical proce-
dures. Table 1 shows the clinical charac-
teristics of study patients divided into
diabetics and nondiabetic patients. A his-
tory of diabetes before admission was
known in 643 patients (20.2%). Com-
pared with subjects without a history of
diabetes, patients with diabetes were
older (61.2  13.2 vs. 55.4  15.9 years,
P  0.001), had higher BMI (29.6  7.8
vs. 26.8  6.9 kg/m
2; P  0.001), were
more likely to be male (52.1 vs. 44.8%;
P  0.001), were of minority ethnic
groups (African Americans 28.8 vs.
21.4%; P  0.001), and were more likely
to undergo high-risk surgical procedures
(8.9 vs. 6%; P  0.012).
The blood glucose level before sur-
gery in the entire cohort was 120  38
mg/dl. Of note, there were no signiﬁcant
differences in blood glucose concentra-
tion between patients included in and
those excluded from the analysis. As ex-
pected, nondiabetic subjects had lower
presurgery blood glucose levels (113 
28mg/dl)thanpatientswithaknownhis-
tory of diabetes (145  51 mg/dl; P 
0.001).Thebloodglucoselevelonthe1st
day after surgery was 155  42 mg/dl in
diabetic patients and 132  28 mg/dl in
nondiabetic subjects; both values were
higher than those reported during the
subsequent hospital stay (139  34 and
115  21 mg/dl, respectively; P  0.01).
After surgery, 40% of patients had mean
blood glucose 140 mg/dl; three-fourths
of these had mean blood glucose between
141 and 180 mg/dl, and the remainder
hadbloodglucose180mg/dl.Clinically
signiﬁcant hyperglycemia (deﬁned as
bloodglucose180mg/dl)wasobserved
in 7.9% of patients before surgery, in
17.2% of subjects on the day of surgery,
and in 9.9% of patients during the post-
operative period (days 2–10).
Mortality and in-hospital complica-
tion rates in patients with and without
diabetes are shown in Fig. 1. The overall
30-day mortality was 2.3% (72 of 3,112
patients), with a higher mortality (3.1%)
observed in diabetic than in nondiabetic
(2.1%) patients, but this difference did
not reach statistical signiﬁcance (P 
0.105). Compared with nondiabetic sub-
jects,diabeticpatientshadahigherrateof
Table 1—Patient characteristics
Variable All Nondiabetic Diabetic P value
n 3,112 2,469 (80) 643 (20)
Age (years) 56.5  16 55.4  15.9 61.2  13.2 0.001
Sex
Female 1,712 (53.8) 1,404 (55.2) 308 (47.9) 0.001
Male 1,472 (46.2) 1,137 (44.8) 335 (52.1) 0.001
BMI (kg/m
2) 27.6  7.3 26.8  6.9 29.6  7.8 0.001
Race
Caucasian 2,161 (71.5) 1,756 (73.2) 405 (65.2) n.s.
African American 693 (23) 514 (21.4) 179 (28.8) 0.001
Hispanic 40 (1.3) 32 (1.3) 8 (1.9) 0.001
Severity of surgery
Low risk 268 (8.4%) 224 (8.8) 44 (6.8) n.s.
Moderate risk 2,707 (85%) 2,165 (85.2) 542 (84.3) n.s.
High risk 209 (6.6%) 152 (6) 57 (8.9) 0.012
Blood glucose before surgery
(mg/dl) 120.4  37.9 112.6  28.2 144.7  51.3 0.001
Blood glucose on the day of
surgery (mg/dl) 137.6  33 132.2  27.6 154.6  41.8 0.001
Average blood glucose after
surgery (mg/dl) 119.9  26.5 114.5  21.2 139.3  33.8 0.001
Hospital LOS (days) 7.4  10.8 7  10.8 8.8  10.6 0.001
Mortality at 30 days 72 (2.26) 52 (2.05) 20 (3.11) n.s.
Data are n (%) or means  SD.
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(12.1 vs. 5.4%; P  0.001), wound and
skin infections (5 vs. 2.3%; P  0.001),
systemic blood infection (3.6 vs. 1.1%;
P  0.001), urinary tract infections (4.5
vs. 1.4%; P  0.001), acute myocardial
infarction (2.6 vs. 1.2%; P  0.008), and
ARF (9.6 vs. 4.8%; P  0.001). In addi-
tion, diabetic patients had higher length
LOS and ICU LOS than nondiabetic sub-
jects (8.8  10.6 vs. 7  10.8 days; P 
0.001 and 2.3  6.2 vs. 1.8  6.5 days;
P  0.01, respectively).
The association between glucose lev-
els before and after surgery and mortality
oddsratiosisshowninFig.2.Wefounda
strong association between mortality and
glucose levels both before surgery (Fig.
2A) and after surgery (Fig. 2B); however,
mortality odds ratios were different be-
tweenpatientswithandwithoutdiabetes.
The risk of death increased in proportion
tobloodglucoselevelsinpatientswithout
a history of diabetes (P  0.001), but the
association of hyperglycemia and mortal-
ity was greater in patients without a his-
tory of diabetes before admission (P 
0.001 for both preoperative and postop-
erative blood glucose) compared with pa-
tients with known diabetes (P  0.78 for
preoperative blood glucose and P  0.51
for postoperative blood glucose). Multi-
variateanalysisadjustedforage,sex,race,
and surgery severity showed that before
surgery blood glucose may be an inde-
pendent predictor of mortality with mar-
ginal signiﬁcance (P  0.063) and
likewisewithpostoperativebloodglucose
concentration(P0.087).Toinvestigate
theeffectofraceonmortalityandhospital
complications, we included African
American race in the multivariate analy-
ses,whichadjustedforage,AfricanAmer-
ican race, diabetes status, interaction
between African American race and dia-
betes,sex,severityofsurgery,andpresur-
gery blood glucose levels. We observed
thatAfricanAmericanpatientswerenotat
increasedriskofmortalitycomparedwith
other races (P  0.96), but they were
more likely to develop complications in-
cluding pneumonia (P  0.0075) and
ARF (P  0.0158) than non–African
Americans. We observed no difference in
blood glucose concentration between ra-
cial groups before or after surgery.
The clinical characteristics of survi-
vorsandnonsurvivorsareshowninTable
2. Compared with survivors, patients
who died had signiﬁcantly higher blood
glucose concentrations before surgery
(133.4  40.9 vs. 119.9  37.7 mg/dl;
P  0.002) and after surgery (126.6 
23.7 vs. 119.7  26.6 mg/dl; P  0.001).
Inaddition,comparedwithsurvivors,de-
ceased patients were older (P  0.001),
the majority of them were men (P 
0.001), they had longer hospital LOS
(1824vs.710days;P0.001),and
they had higher rates of ARF (30.6 vs.
Figure 1—Thirty-day mortality and in-hospital complication rates in patients with and without
diabetes: blood infection (combined bacteriemia and sepsis); urinary tract infection (UTI), acute
myocardial infarction (AMI), and ARF. *P  0.001; †NS; ‡P  0.017.
Figure 2—Mean blood glucose concentration before (A) and after surgery (B) and odds ratio for
30-day mortality in patients with and without diabetes. F, all patients; f, diabetic patients; Œ,
nondiabetic patients.
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(16.7vs.2.2%;P0.01).Inaddition,we
found that age, male sex, development of
hyperglycemia before or after surgery,
blood infections, and acute myocardial
infarction were predictors of 30-day
mortality.
CONCLUSIONS — Our study indi-
cates that perioperative hyperglycemia is
associated with increased risk of hospital
complications in patients undergoing
noncardiac surgery. Perioperative hyper-
glycemia signiﬁcantly increased the risk
of pneumonia, systemic blood infections,
urinary tract infection, skin infections,
andARFduringthepostoperativeperiod.
In addition, we found a signiﬁcant asso-
ciation between blood glucose concentra-
tion and mortality; however, the impact
of hyperglycemia on mortality rate was
more signiﬁcant among patients without
a history of diabetes compared with those
with known diabetes before admission.
The association between hyperglyce-
miaandincreasedriskofhospitalcompli-
cations and mortality in critically ill
(1,8,12,13) patients undergoing major
cardiovascular surgery (12,16,17) is well
established. Less information is available
on the signiﬁcance of hyperglycemia in
those undergoing general and noncardiac
surgery. Small observational studies in
noncardiac surgery patients have re-
ported that postsurgical hyperglycemia is
associated with infectious complications
in general surgery patients (10). In pa-
tients with hyperglycemia (blood glucose
220 mg/dl) on postoperative day 1, the
infection rate was 2.7 times that observed
(31.3 vs. 11.5%) in diabetic patients with
all serum glucose values 220 mg/dl
(10).Whenminorinfectionoftheurinary
tract was excluded, the relative risk for
“serious” postoperative infection (sepsis,
pneumonia, and wound infection) in-
creased to 5.7 when any postoperative
day 1 blood glucose level was 220 mg/
dl. Ramos et al. (14) showed an increase
in postoperative infection rate by 30% for
every40mg/dlriseinpostoperativeblood
glucose levels 110 mg/dl and increased
length of hospital stay in general and vas-
cular surgery patients independent of
their diabetes status. The results of our
studyconﬁrmtheassociationbetweenin-
creased length of hospital stay and risk of
hospital complications and mortality in
patients with blood glucose levels 150
mg/dl, particularly in those who did not
have a prior diagnosis of diabetes (7,18).
We and other investigators (7,19–21) re-
ported previously that the development
of hyperglycemia in hospitalized patients
without a history of diabetes is an impor-
tant outcome marker associated with
worse clinical outcome compared with
that of those with a previous history of
diabetes or with normoglycemia.
To investigate the effect of race on
mortality and hospital complications,
we included African American race in
the multivariate analyses, which ad-
justed for age, diabetes status, sex, se-
verityofsurgery,andglucoselevels.We
observedthatAfricanAmericanpatients
had mortality rates similar to those of
other races (P  0.96), but they were
more likely to develop complications
including pneumonia (P  0.0075) and
ARF (P  0.0158) than non–African
Americans. We observed no difference
in blood glucose concentration among
racial groups before or after surgery;
thus,theobserveddifferenceinhospital
complications cannot be explain by dif-
ferences in glycemic control among ra-
cial groups. This observation needs to
be conﬁrmed in future studies in differ-
ent inpatient clinical settings with par-
ticular attention to severity of illness
and presence of comorbidities. The rea-
sons for poor outcome with high blood
glucose levels remain unclear. Much of
the attention has focused on increased
rate of infections and poor wound heal-
ing (1,22). Hyperglycemia is associated
with impaired leukocyte function, in-
cluding decreased phagocytosis, im-
paired bacterial killing, and chemotaxis
(23). Hyperglycemia has also been
shown to impair collagen synthesis and
to impair wound healing among pa-
tients with poorly controlled diabetes
(22). Acute hyperglycemia activates the
oxidative pathway through increased
generation of reactive oxygen species.
Reactiveoxygenspeciescausedirecttis-
sue damage by lipid oxidation and neu-
tralize nitric oxide, which impairs
vasodilation and reduces tissue perfu-
sion (24). The proinﬂammatory path-
way is also activated through nuclear
factor-B activation. This leads to pro-
duction of inﬂammatory cytokines such
as tumor necrosis factor-, interleu-
kin-6, and plasminogen activator inhi-
bitior-1, which causes increased
vascular permeability and leukocyte
and platelet activation (24). Similarly,
acute hyperglycemia and oscillating
glucoselevelshavebeenshowntocause
higher levels of oxidative stress and en-
dothelial dysfunction than chronic and
sustained hyperglycemia (25).
The main limitation of this study is
its retrospective nature. Our study did
not address the question of whether
treatment of hyperglycemia may reduce
hospital complications or mortality
during the perioperative period. Al-
though several prospective randomized
trials in patients undergoing coronary
bypass surgery have shown that aggres-
sive glycemic control reduces short-
and long-term mortality and systemic
infections, it is not clear whether inten-
siﬁed insulin therapy in general surgery
will improve clinical outcome and
lower mortality. Our group is currently
conducting a prospective, randomized
trialofstrictglycemiccontroltoaddress
these issues.
In summary, perioperative hyper-
glycemia is associated with increased
in-hospital morbidity, hospital and ICU
Table 2—Clinical characteristics of survivors and nonsurvivors
Variable Survivors Nonsurvivors P value
n 3,112 (98.1) 72 (1.9)
Age (years) 56  16 65  14 0.001
Sex: male/female (%) 46/54 67/33 0.001
Blood glucose (mg/dl)
Before surgery 118  38 132  42 0.001
Day of surgery 138  32 143  28 0.028
After surgery (days 2–10) 122  28 130  27 0.007
ARF 163 (5.2) 22 (30.5) 0.001
Pneumonia 194 (6.2) 22 (30.5) 0.001
Sepsis 95 (3) 14 (19.4) 0.001
Acute myocardial infarction 65 (2) 7 (9.7) 0.001
Hospital LOS (days) 7.2  10.8 18  24 0.001
ICU LOS (days) 1.8  6.4 14.7  23 0.001
Data are n (%) or means  SD.
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well as age, sepsis, pneumonia, ARF,
and acute myocardial infarction were
other important predictors of mortality.
These results suggest that hyperglyce-
mia is harmful and should be treated
during the perioperative period in gen-
eral surgical patients. The fact that pa-
tients without a history of diabetes
(stress hyperglycemia) experience
worseoutcomeandhighermortalityata
glucose level the same as that for those
with a known history of diabetes sug-
gests a lack of adaptation to acute hy-
perglycemia and its associated
inﬂammatory and oxidative state. Our
results underscore the need for pro-
spective trials to assess the impact of
glycemic control during the periopera-
tive period in surgery patients.
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